Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19224751 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer
Condition: Colon Cancer
Intervention: Biological: Ad5-hGCC-PADRE vaccine

Study has passed its completion date and status has not been verified in more than two years.